Key Points Covered
- Market estimates and forecast 2015-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Automated Breast Ultrasound System Market and How to Navigate
- Recommendation on Key Winning Strategies
Future Outlook for Automated Breast Ultrasound Systems Market Looks Brighter in Comparison to Historic Growth
According to the report by Future Market Insights, the demand for automated breast ultrasound system [ABUS] has been increasing significantly with rising prevalence of breast cancer across the globe. According to a report published by American Society of Clinical Oncology, In India 162,468 new cases of breast cancer were reported in 2018. Also, breast cancer accounted for 11% of all cancer deaths in India according to the study.
Major progress has been witnessed with 3D automated breast ultrasound system, especially when complemented full-field digital screening mammography (FFDSM) owing to relatively higher accuracy in invasive breast cancer diagnosis and faster recall features.
A slight drop in the demand was observed in the initial half of 2020, attributed to the imposition of stringent lockdowns amid the COVID-19 pandemic. Pandemic compelled the doctors to limit the breast ultrasound procedures to urgent and critical patients only.
The steps were taken to break the transmission chain of the virus. The skilled professionals were allocated towards tending the COVID patients thus restricting the market demand. However, strong recovery is in stores as breast cancer cases are surging globally.
In the future, the market is poised to grow significantly, as majority of diagnostics centers are switching towards automated breast ultrasound system from radiology and MRI techniques. India and U.K are likely to yield highly opportunistic prospects, contributing towards the overall expansion of the market.
How is Launch of Novel Technologies Affecting ABUS Market?
Rising necessity of accurate diagnosis of breast lesions especially during early stages of cancer and lack of skilled radiologists to operate the conventional ultrasound system is promoting major manufacturing companies towards developing modern, precise and automated diagnosis system.
Implementation of high frequency sound waves to map the entire breast and create 3D monochromatic image of tissues and breast structure has fueled the market demand. Surging incidence of breast cancer is also attributed to increasing preference towards sedentary lifestyle and obesity.
According to World Health Organization, more than 50% of women in Latin America are suffering from obesity. Several leading organizations are investing in research and development to offer novel technologies for timely diagnosis.
For instance, GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.
Integration of automated breast ultrasound system with other digital cancer screening operations and procedures will yield more accurate prognosis and will promote rapid adoption of ABUS in diagnostics laboratories.
According to a report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%. The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time.
Studies highlighting the benefits of automated breast ultrasound systems will create attractive opportunities for the market in the coming years.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What are the Major Challenges Hindering Automated Breast Ultrasound Systems Market?
A radiologist with expertise in ABUS is required to correctly interpret the volumetric 3D images and identify the region of breast lesion. Lack of skilled radiologists and increased cost of standardized training is hampering the market growth.
Lack of awareness in emerging economies regarding breast cancer and underdeveloped healthcare infrastructure in poor countries are also hindering the market growth.
According to Winship Cancer Institute, breast ultrasound system is more susceptible to produce false positive than mammography. Breast ultrasound system is also not equipped to indicate whether the tumor is benign or cancerous.
Inability to display calcification among women aged above 45 years is a major area of concern among the market players.
How is the Automated Breast Ultrasound Systems Market expanding in the U.S?
The automated breast ultrasound systems market in U.S. is anticipated to grow exponentially during the forecast period due to growing prevalence of breast cancer across the country.
According to American Society of Cancer, in 2021 nearly 281,550 new cases of breast cancer will be detected in women with 43,600 women dying with breast cancer.
The rising incidence of breast cancer will fuel the demand for advanced breast imaging technologies and promote effective treatments. Increasing government campaigns to spread awareness and educate women about breast cancer and importance of screening will boost the ABUS market in U.S.
Awareness initiatives undertaken by various foundations in the U.S. include National Breast Cancer Awareness (NBCA) month by American Society of Cancer, awareness campaigns run by National Breast Cancer Foundation, and Susan Komen foundation. These will positively influence the demand of automated breast ultrasound systems for screening of breast cancer in dense breast tissue.
Why is the UK expected to be a Highly Lucrative Market?
Presence of developed healthcare infrastructure and increased consumer spending on healthcare are key automated breast ultrasound systems market drivers in U.K. According to Cancer Research U.K, in 2017 approximately 54,700 new cases of breast cancer were detected in women. Growing instances of cancer will boost the demand for advanced non invasive breast imaging technologies.
Increasing mortality rate due to breast cancer will fuel the demand for developing modern cancer screening technology. Rising prevalence of obesity and growing alcohol abuse is propelling the breast cancer cases, thereby accelerating product demand. With improve efficiency and effectiveness of ABUS than mammography system a steady market growth is expected during the forecast period.
Why Is Demand for Automated Breast Ultrasound Systems Market Surging In Germany?
According to the German Center for Cancer Registry Data, breast cancer is the most common form of cancer in Germany with approximately 67,000 new cases of breast cancer was observed in women in 2017.
Presence of market leaders like Siemens along with modern healthcare system will boost the ABUS market in Germany during the forecast period. High per capita income and increased awareness regarding the screening of breast cancer will positively influence the demand of automated breast ultrasound systems.
Market players are working towards optimizing the automated breast ultrasound market in compliance with the strict government regulations and policies in Germany.
How Lucrative is the Opportunity in the Saudi Arabia?
Rapid urbanization and increasing spending power of consumer in Saudi Arabia will offer novel market growth opportunities. Establishment of state of the art cancer diagnostics centers like King Abdullah Medical City-Oncology Center will positively influence the demand for automated breast ultrasound system market.
Increasing government and private funding along with favorable insurance policies will boost the ABUS market sales. According to Global Cancer Observatory, breast cancer comprised of nearly 14.2% of total new cancer incidences in Saudi Arabia in 2020.
Increasing prevalence of breast cancer will promote the research and development of ABUS technology providing further momentum to automated breast ultrasound systems market growth.
What Is Driving Adoption Of Cancer Diagnostics In India?
Market growth in India is expected to happen at a faster rate. The Breast Cancer India has reported that in 2018, about 27.7% of all new cancer cases diagnosed in women were breast cancers.
Rising population and increasing per capita income will provide a favorable climate for automated breast ultrasound systems market growth. The report also states that in 2018, India had the second highest breast cancer mortality rate with 87,090 women losing their lives to breast cancer.
These numbers indicate huge market penetration potential in India. Growing government initiatives to spread awareness regarding breast cancer among women and campaigns to reduce the mortality rate will be key factors driving growth in the market.
Which End User Exhibit Higher Application of Automated Breast Ultrasound Systems?
Hospitals and related services are anticipated to generate highest demand throughout the forecast period. Growing pool of patients and faster accessibility of medical tools and equipments and presence of skilled personnel will elevate the demand in Hospitals.
Automated Breast Ultrasound Systems – Competitive Landscape
Key market players in automated breast ultrasound system market are focusing on installing ABUS in hospitals and diagnostics center in order to expand their global footprint. They are also working towards developing the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products. For instance:
- Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.
- Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.
- Siemens Healthineers AG introduced a new automated breast ultrasound system “ACUSON S2000 ABVS” as a part of its imaging, diagnostics segment with 3D imaging feature required to find the lesions in fatty and dense breast tissue.
Automated breast ultrasound system named “AWBUS” made by SonoCiné is capable of providing repeated scans of whole breast with same consistency and accuracy necessary for accurate detection of cancer.
Future Market Insights has also analyzed the following players in the automated breast ultrasound system market in its detailed report*:
- GE Electric Co.
- Siemens A.G.
- Hitachi Ltd.
- SonoCiné Inc.
*This list is indicative - full details about the micro irrigation systems market players are available upon request.
Automated Breast Ultrasound Systems Market - Report Scope
Historical Data Available for
US$ Mn for Value & ‘000 Units for Volume
Key Regions Covered
North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa
Key Countries Covered
U.S., Canada, Brazil, Mexico, Argentina, EU-5, BENELUX, NORDIC, Poland, Russia, Japan, China, India, ASEAN Countries, Australia & New Zealand, Rest of APEJ, GCC Countries, South Africa, Israel, Turkey, Iran, Rest of Middle East & Africa
Key Segments Covered
Key Companies Profiled
Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis
Customization & Pricing
Available upon Request
Enquiry before Buying
- Is the market research conducted by Future Market Insights?
Yes, the report has been compiled by expert analysts of Future Market Insights, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
- What research methodology is followed by Future Market Insights?
FMI follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
- Who are the respondents for primary research?
FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.
- How can I buy this report?
FMI provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely
Key Segments Covered
By End User
- Diagnostic Imaging Laboratories
- North America
- Latin America
- Rest of Latin America
- Western Europe
- BENELUX (Belgium, Netherlands, Luxembourg)
- NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
- Rest of Europe
- Eastern Europe
- Rest of Eastern Europe
- APEJ (Asia Pacific excluding Japan)
- ASEAN Countries
- Australia & New Zealand
- Rest of APEJ
- GCC Countries
- South Africa
- Rest of Middle East & Africa